08:28:30 EST Sun 15 Dec 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Canada House Wellness Group Inc
Symbol CHV
Shares Issued 194,189,765
Close 2018-12-21 C$ 0.125
Recent Sedar Documents

Canada House receives Health Canada pot sales licence

2018-12-24 07:59 ET - News Release

Mr. Steve Low reports

CANADA HOUSE RECEIVES CANNABIS SALES LICENSE FROM HEALTH CANADA

Canada House Wellness Group Inc. has received approval from Health Canada to sell cannabis, effective Dec. 21, 2018, in accordance with sections 27 and 289 of the Cannabis Regulations under the Cannabis Act. This approval comes by way of amendment to the licence held by the company's wholly owned subsidiary and licensed producer, Abba Medix Corp., to include the sale of dried cannabis, cannabis oil, seeds, cannabis plants and fresh cannabis for medical purposes.

"What a way to end the year! We are thrilled to finally secure this licence and begin selling premium medical grade cannabis in support of the medical market and our medical patient base," commented Chris Churchill-Smith, chief executive officer of Canada House. "This licence marks a major milestone since the very inception of our company and is a testament to the quality of our staff, production capabilities and industry leading SOPs. As we finalize the completion of our production facility, we look forward to our new reality of being a fully licensed LP, which marks the next step in our journey to profitability and providing our shareholder base with undeniable value," added Mr. Churchill-Smith.

Riley McGee, president of Abba, added: "This is the culmination of what has been an amazing year for our team at Abba. To name but a few of our recent successes, we have secured the exclusive distribution rights to world-class genetics, completed several seed sales to other Canadian licensed producers, validated Medicine Man's world-class grow methodologies within our 22,000-square-foot facility, completed multiple bulk purchases of cannabis, and have harvested four batches of our own premium medical cannabis. We are on track to be in full capacity flower production for the first quarter of 2019 and aim and fully expect to be an industry leader in terms of quality and consistency of our flower. This licence could not have come at a better time for Canada House and its medical patients as product shortages continue to impact the medical and recreational markets."

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.